\
&
Contact us
\
&
Contact us
This was 5 years ago
LocationOnline
ProgrammesAn info day gives prospective applicants (and other stakeholders of EU research and innovation) the opportunity to get information and ask questions about what’s new, and thus grasp the best possible overview of the upcoming call topics. This event complements the brokerage event on digital topics and on industry topics.
The programme for Cluster 4 is as follows
09:00 Presentation of Horizon Europe and Cluster: intervention Logic
11:00 Horizontal Issues
13:15 Parallel Sessions
> Destination 1: CLIMATE NEUTRAL, CIRCULAR AND DIGITISED PRODUCTION
> Destination 6: A HUMAN-CENTRED AND ETHICAL DEVELOPMENT OF DIGITAL AND INDUSTRIAL TECHNOLOGIES
> Destination 5: OPEN STRATEGIC AUTONOMY IN DEVELOPING, DEPLOYING AND USING GLOBAL SPACE-BASED INFRASTRUCTURES, SERVICES, APPLICATIONS AND DATA
09:00
> Destination 6: A HUMAN-CENTRED AND ETHICAL DEVELOPMENT OF DIGITAL AND INDUSTRIAL TECHNOLOGIES
10:30 Parallel Sessions
> Destination 2: INCREASED AUTONOMY IN KEY STRATEGIC VALUE CHAINS FOR RESILIENT INDUSTRY (GROW)
> Destination 3: WORLD LEADING DATA AND COMPUTING TECHNOLOGIES
12:15
> Destination 4: DIGITAL AND EMERGING TECHNOLOGIES FOR COMPETITIVENESS AND FIT FOR THE GREEN DEAL
14:30 Parallel Sessions
> Destination 2: INCREASED AUTONOMY IN KEY STRATEGIC VALUE CHAINS FOR RESILIENT INDUSTRY (GROW)
> Destination 4: DIGITAL AND EMERGING TECHNOLOGIES FOR COMPETITIVENESS AND FIT FOR THE GREEN DEAL
All further information (including links to the webstreams and slido for questions) can be found on https://www.horizon-europe-infodays2021.eu/event/cluster-4-digital-industry-space
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
